Zevra Therapeutics Inc. – Filings and Transcripts

NASDAQ: ZVRA
Share price (8/12/26): $11.44
Market cap (8/12/26): $679 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus for primary offering

Ownership Filter

Watton Corey Michael

Vanguard Capital Management LLC

Thompson Rahsaan

News Filter

Reports Second Quarter 2026 Financial Results and Corporate Update

Shareholder Vote Results, Financial Statements or Exhibits

Reports First Quarter 2026 Financial Results and Corporate Update

Sells SDX Portfolio to Commave Therapeutics for $50 Million

Reports Fourth Quarter and Full Year 2025 Financial Results

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Proxy in contested situation

Other Filter

Letter from the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC